|
|
 Previous Article | Table of Contents | Next Article 
Severe combined immunodeficiency mice engrafted with human T cells, B
cells, and myeloid cells after transplantation with human fetal bone marrow
or liver cells and implanted with human fetal thymus: a model for studying
human gene therapy
S Yurasov, TR Kollmann, A Kim, CA Raker, M Hachamovitch, F Wong-Staal and H Goldstein
Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY
10461, USA.
To develop an in vivo model wherein human hematopoiesis occurs, we
transplanted severe combined immunodeficiency (SCID) mice with either human
fetal bone marrow (HFBM) or human fetal liver (HFL). After transplantation
of SCID mice with cultured HFBM (BM-SCID-hu mice) or HFL cells (Liv-SCID-hu
mice), significant engraftment of the mouse bone marrow (BM) and population
of the peripheral blood with human leukocytes was detected. Human
colony-forming unit-granulocyte macrophage and burst forming unit-erythroid
were detected in the BM of the BM-SCID-hu and Liv-SCID-hu mice up to 8
months after transplantation. When the HFBM or HFL cells were transduced
with a retroviral vector before transplantation, integrated retroviral
sequences were detected in human precursor cells present in the SCID mouse
BM and in leukocytes circulating in the peripheral blood (PB) up to 7
months after transplantation. The PB of the BM-SCID-hu mice also became
populated with human T cells after implantation with human thymic tissue,
which provided a human microenvironment wherein human pre-T cells from the
BM could mature. When the HFBM was retrovirally transduced before
transplantation, integrated retrovirus was detected in sorted CD4+CD8+
double positive and CD4+ single positive cells from the thymic implant and
CD4+ cells from the PB. Taken together, these data indicated that the BM of
our BM-SCID-hu and Liv-SCID-hu mice became engrafted with retrovirally
transduced human hematopoietic precursors that undergo the normal human
hematopoietic program and populate the mouse PB with human cells containing
integrated retroviral sequences. In addition to being a model for studying
in vivo human hematopoiesis, these mice should also prove to be a useful
model for investigating in vivo gene therapy using human stem/precursor
cells.
Volume 89,
Issue 5,
pp. 1800-1810,
03/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. Lan, L. Wang, B. Diouf, H. Eguchi, H. Su, R. Bronson, D. H. Sachs, M. Sykes, and Y.-G. Yang
Induction of human T-cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism
Blood,
May 15, 2004;
103(10):
3964 - 3969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Saito, Y. Kametani, K. Hozumi, N. Mochida, K. Ando, M. Ito, T. Nomura, Y. Tokuda, H. Makuuchi, T. Tajima, et al.
The in vivo development of human T cells from CD34+ cells in the murine thymic environment
Int. Immunol.,
October 1, 2002;
14(10):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. E. Nicolini, S. Imren, I.-H. Oh, R. K. Humphries, P. Leboulch, M. E. Fabry, R. L. Nagel, and C. J. Eaves
Expression of a human beta -globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells
Blood,
July 30, 2002;
100(4):
1257 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Pilarski, G. Hipperson, K. Seeberger, E. Pruski, R. W. Coupland, and A. R. Belch
Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice
Blood,
February 1, 2000;
95(3):
1056 - 1065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Crisa, V. Cirulli, K. A. Smith, M. H. Ellisman, B. E. Torbett, and D. R. Salomon
Human Cord Blood Progenitors Sustain Thymic T-Cell Development and a Novel Form of Angiogenesis
Blood,
December 1, 1999;
94(11):
3928 - 3940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. E. Nicolini, T. L. Holyoake, J. D. Cashman, P. P.Y. Chu, K. Lambie, and C. J. Eaves
Unique Differentiation Programs of Human Fetal Liver Stem Cells Shown Both In Vitro and In Vivo in NOD/SCID Mice
Blood,
October 15, 1999;
94(8):
2686 - 2695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Robin, F. Pflumio, W. Vainchenker, and L. Coulombel
Identification of Lymphomyeloid Primitive Progenitor Cells in Fresh Human Cord Blood and in the Marrow of Nonobese Diabetic-Severe Combined Immunodeficient (NOD-SCID) Mice Transplanted with Human CD34+ Cord Blood Cells
J. Exp. Med.,
May 17, 1999;
189(10):
1601 - 1610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C.M. van der Loo, H. Hanenberg, R. J. Cooper, F.-Y. Luo, E. N. Lazaridis, and D. A. Williams
Nonobese Diabetic/Severe Combined Immunodeficiency (NOD/SCID) Mouse as a Model System to Study the Engraftment and Mobilization of Human Peripheral Blood Stem Cells
Blood,
October 1, 1998;
92(7):
2556 - 2570.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Dazzi, D. Capelli, R. Hasserjian, F. Cotter, M. Corbo, A. Poletti, W. Chinswangwatanakul, J. M. Goldman, and M. Y. Gordon
The Kinetics and Extent of Engraftment of Chronic Myelogenous Leukemia Cells in Non-Obese Diabetic/Severe Combined Immunodeficiency Mice Reflect the Phase of the Donor's Disease: An In Vivo Model of Chronic Myelogenous Leukemia Biology
Blood,
August 15, 1998;
92(4):
1390 - 1396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Greiner, R. A. Hesselton, and L. D. Shultz
SCID Mouse Models of Human Stem Cell Engraftment
Stem Cells,
May 1, 1998;
16(3):
166 - 177.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Conneally, C.J. Eaves, and R.K. Humphries
Efficient Retroviral-Mediated Gene Transfer to Human Cord Blood Stem Cells With In Vivo Repopulating Potential
Blood,
May 1, 1998;
91(9):
3487 - 3493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
